Tenofovir decrease hepatocellular carcinoma recurrence in chronic hepatitis B patients after liver resection

被引:0
作者
Min Zhang
Dexin Wang
Haidong Liu
Hui Li
机构
[1] Qingdao NO.6 People’s Hospital,Department of Gastroenterology
[2] Qingdao NO.6 People’s Hospital,10th Department of Hepatology
[3] Jining NO.1 People’s Hospital,Invasive Technology Department
来源
Infectious Agents and Cancer | / 13卷
关键词
Tenofovir; Entecavir; Chronic hepatits B; Hepatocellular carcinoma; Nucleus(t)ide analogues;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 189 条
[1]  
Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108
[2]  
Bray F(2016)Cancer statistics in China, 2015 CA Cancer J Clin 66 115-132
[3]  
Siegel RL(2015)The updated incidences and mortalities of major cancers in China 2011 Chin J Cancer 34 502-507
[4]  
Ferlay J(2000)Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis J Clin Oncol 18 1094-1101
[5]  
Lortet-Tieulent J(2008)A new prognostic system for hepatocellular carcinoma including recurrent cases: a study of 861 patients in a single institution J Clin Gastroenterol 42 317-322
[6]  
Jemal A(2008)Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection Liver Int 28 393-401
[7]  
Chen W(2011)Hepatocellular carcinoma N Engl J Med 365 1118-1127
[8]  
Zheng R(2018)Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) related hepatocellular carcinoma Open Virol J 12 26-32
[9]  
Baade PD(2011)Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures J Epidemiol 21 401-416
[10]  
Zhang S(2012)Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity Vaccine 30 2212-2219